Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
| Image |  |
|---|---|
| Description | scientific article published on 01 February 2019 |
| Author/s |
author: Corinne Faivre-Finn Enriqueta Felip Matthias Guckenberger |
| Publication date | February 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |